Medacta GMK Sphere® Multicenter Post-Market Outcomes Study

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 5, 2024

Study Completion Date

December 5, 2024

Conditions
Osteoarthritis
Interventions
DEVICE

Medacta GMK Sphere® Medial Knee Prosthesis

"There is no consensus within the Arthroplasty community as to whether a traditional post and cam-style Posterior Stabilized total knee device is superior to a medial-pivot, more congruent device. However, the majority of surgeons seem to prefer the former, though there is a minority that uses the latter device with great success.~To date, there have been few prospective trials directly comparing these devices, and none with the latest generation of Total Knee Arthroplasty implants. Almost all such studies have been retrospective and/or utilizing older generation devices."

Trial Locations (5)

60611

Norhtwestern University, Chicago

70112

Tulane University, New Orleans

73103

McBride Orthopedic Hospital, Oklahoma City

78759

Texas Orthopedics, Austin

99218

Spokane Joint Replacement Center, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medacta USA

INDUSTRY

NCT02501733 - Medacta GMK Sphere® Multicenter Post-Market Outcomes Study | Biotech Hunter | Biotech Hunter